相关实验视频

Updated: Jul 21, 2025

Real-time Visualization and Analysis of Chondrocyte Injury Due to Mechanical Loading in Fully Intact Murine Cartilage Explants

Real-time Visualization and Analysis of Chondrocyte Injury Due to Mechanical Loading in Fully Intact Murine Cartilage Explants

Published on: January 7, 2019

DLX5促进Col10a1的表达和软骨细胞的缩,并与骨关节炎的进展有关

Jinnan Chen¹, Fangzhou Chen^1,2, Xuan Wu¹

¹Department of Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, Jiangsu 212013, China.

Genes & diseases

|July 26, 2023

概括

距离无本体5 (DLX5) 促进X型原体 (COL10A1) 表达和状细胞缩,这是骨关节炎 (OA) 病变的关键因素. DLX5可能与RUNX2合作调节COL10A1,为OA提供潜在的治疗点.

科学领域:

分子生物学分子生物学
细胞生物学细胞生物学
生物化学生物化学

背景情况:

骨关节炎 (OA) 的特点是关节软骨的退化和有限的修复能力.
冠状细胞缩和X型原体 (COL10A1) 基因表达增加与OA有关.
了解COL10A1和冠状细胞缩的调节者对于OA干预至关重要.

研究的目的:

为了研究远距离不 homeobox 5 (DLX5) 在调节小鼠Col10a1基因表达中的作用.
为了检查DLX5对状细胞缩的控制在状细胞模型中.
为了确定DLX5在小鼠骨关节炎模型中的参与.

主要方法:

定量实时PCR (qRT-PCR) 和西斑分析用于测量基因和蛋白质水平.
双化酶记者测定和染色体免疫沉 (ChIP) 测定以评估基因调节.
建立一种小鼠OA模型,用于体内实验.

主要成果:

过敏性冠状细胞 (MCT和ATDC5细胞) 中DLX5和COL10A1水平显著增加.
DLX5直接与Col10a1cis增强剂相互作用,促进其活性.
在OA小鼠的关节软骨和底骨中观察到增加的COL10A1和DLX5.
DLX5的过度表达在过度缩的红细胞中调节了RUNX2,这表明有合作作用.

结论:

DLX5是Col10a1表达和冠状细胞缩的关键调节者.
DLX5可能与RUNX2合作,控制细胞特异的Col10a1表达.
DLX5在骨关节炎的发病过程中起着重要作用.

关键词:

冠状细胞过度缩小冠状细胞过高在Col10a1中,表达式是在 DLX5 中使用 DLX5 骨关节炎是一种骨关节炎.在RUNX2中使用RUNX2.

更多相关视频

Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs

Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs

Published on: January 27, 2023

Co-localization of Cell Lineage Markers and the Tomato Signal

Co-localization of Cell Lineage Markers and the Tomato Signal

Published on: December 28, 2016

相关概念视频

Bone Formation by Endochondral Ossification

Bone Formation by Endochondral Ossification

Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...

Growth of Cartilage and Bone Tissue

Growth of Cartilage and Bone Tissue

Chondrocytes form a temporary cartilaginous model by dividing and secreting a thick gel-like extracellular matrix. Once the chondrocytes undergo programmed cell death, osteoblasts enter the site of the cartilaginous model. The process of replacing the temporary cartilaginous model with bone in an ordered manner is called endochondral ossification. In endochondral ossification, not all of the cartilage is replaced by bone tissue. Some cartilage that performs a protective and supportive function...

Osteoclasts in Bone Remodeling

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...

TGF - β Signaling Pathway

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...